More articles from Research Article

Extracellular vesicle-mediated in vitro transcribed mRNA delivery for treatment of HER2+ breast cancer xenografts in mice by prodrug CB1954 without general toxicity
Alexis V. Forterre, Jing-Hung Wang, Alain Delcayre, Kyuri Kim, Carol Green, Mark D Pegram, Stefanie S Jeffrey, A.C. Matin

Molecular Cancer Therapeutics Jan 2020, molcanther.0928.2019; DOI: 10.1158/1535-7163.MCT-19-0928
KLF4 p.A472D Mutation Contributes to Acquired Resistance to Cetuximab in Colorectal Cancer
Song Ye, Xiaoge Hu, Chao Ni, Weiwei Jin, Yaping Xu, Lianpeng Chang, Huaixiang zhou, Jiahong Jiang, Liu Yang

Molecular Cancer Therapeutics Jan 2020, molcanther.1385.2018; DOI: 10.1158/1535-7163.MCT-18-1385
Preclinical activity of ribociclib in squamous cell carcinoma of the head and neck
Gabrielle van Caloen, Sandra Schmitz, Mariama El Baroudi, Xavier Caignet, Sébastien Pyr dit Ruys, Pierre P Roger, Didier Vertommen, Jean-Pascal Machiels

Molecular Cancer Therapeutics Jan 2020, molcanther.0695.2019; DOI: 10.1158/1535-7163.MCT-19-0695
Efficacy of FGFR inhibitors and combination therapies for acquired resistance in FGFR2-fusion cholangiocarcinoma
Melanie A. Krook, Alexandria Lenyo, Max Wilberding, Hannah Barker, Mikayla Dantuono, Kelly M Bailey, Hui-Zi Chen, Julie W Reeser, Michele R. Wing, Jharna Miya, Eric Samorodnitsky, Amy M. Smith, Thuy Dao, Dorrelyn M Martin, Kristen K Ciombor, John Hays, Aharon G Freud, Sameek Roychowdhury

Molecular Cancer Therapeutics Jan 2020, molcanther.0631.2019; DOI: 10.1158/1535-7163.MCT-19-0631
Targeting tumor neoangiogenesis via targeted adenoviral vector to achieve effective cancer gene therapy for disseminated neoplastic disease
Myungeun Lee, Zhi Hong Lu, Jie Li, Elena A. Kashentseva, Igor P. Dmitriev, Samir A. Mendonca, David T. Curiel

Molecular Cancer Therapeutics Jan 2020, molcanther.0768.2019; DOI: 10.1158/1535-7163.MCT-19-0768
Tankyrase inhibitors target colorectal cancer stem cells via AXIN-dependent downregulation of c-KIT tyrosine kinase
Myung-Kyu Jang, Tetsuo Mashima, Hiroyuki Seimiya

Molecular Cancer Therapeutics Jan 2020, molcanther.0668.2019; DOI: 10.1158/1535-7163.MCT-19-0668
Genomic and expression analyses define MUC17 and PCNX1 as predictors of chemotherapy response in breast cancer
Waleed S Al Amri, Lisa M Allinson, Diana E Baxter, Sandra M Bell, Andrew M. Hanby, Stacey J Jones, Abeer M Shaaban, Lucy F Stead, Eldo T Verghese, Thomas A Hughes

Molecular Cancer Therapeutics Jan 2019, molcanther.0940.2019; DOI: 10.1158/1535-7163.MCT-19-0940
Pin1 inhibition sensitizes chemotherapy in gastric cancer cells by targeting stem-cell like traits and multiple biomarkers
Zhen-Zhen Zhang, Wei-Xing Yu, Min Zheng, Xin-Hua Liao, Ji-Chuang Wang, Da-Yun Yang, Wen-Xian Lu, Long Wang, Sheng Zhang, He-Kun Liu, Xiao Zhen Zhou, Kun Ping Lu

Molecular Cancer Therapeutics Jan 2019, molcanther.0656.2019; DOI: 10.1158/1535-7163.MCT-19-0656
Targeting phosphorylation of Y-box binding protein YBX1 by TAS0612 and everolimus in overcoming antiestrogen resistance
Tomohiro Shibata, Kosuke Watari, Akihiko Kawahara, Tomoya Sudo, Satoshi Hattori, Yuichi Murakami, Hiroto Izumi, Junji Itou, Masakazu Toi, Jun Akiba, Yoshito Akagi, Maki Tanaka, Michihiko Kuwano　, Mayumi Ono

Molecular Cancer Therapeutics Jan 2019, molcanther.0690.2019; DOI: 10.1158/1535-7163.MCT-19-0690
Development of AO-176, a Next Generation Humanized Anti-CD47 Antibody With Novel Anti-Cancer Properties and Negligible Red Blood Cell Binding
Robyn J Puro, Myriam N Bouchlaka, Ronald R Hiebsch, Benjamin J Capoccia, Michael J Donio, Pamela T Manning, William A Frazier, Robert W Karr, Daniel S Pereira

Molecular Cancer Therapeutics Jan 2019, molcanther.1079.2019; DOI: 10.1158/1535-7163.MCT-19-1079

Main menu

User menu

Search

More articles from Research Article

Pages

Articles

Info for

About MCT